リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Different Risk Factors are Associated with Vascular Access Patency after Construction and Percutaneous Transluminal Angioplasty in Patients Starting Hemodialysis」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Different Risk Factors are Associated with Vascular Access Patency after Construction and Percutaneous Transluminal Angioplasty in Patients Starting Hemodialysis

吉田 真帆子 広島大学

2021.03.23

概要

Background: The objective of this multicenter, prospective observational study was to determine the factors related to patency rates after construction of vascular access (VA) and the first percutaneous transluminal angioplasty (PTA).

Methods: The 24-month primary and secondary patency rates after construction of a radiocephalic arteriovenous fistula (RC-AVF) and arteriovenous graft (AVG) were evaluated using the Kaplan–Meier method and log-rank test. The 12-month post-PTA patency rate was also investigated. A Cox proportional hazard model was used to identify clinical parameters associated with the primary patency rate and the post-PTA patency rate.

Results: A total of 611 patients were enrolled in the study. The primary patency rate after VA construction was lower in hemodialysis (HD) patients with an AVG than in those with an AVF. Aging (hazard ratio [HR], 1.02 per 1 year; P<0.001), female sex (HR, 1.41; P=0.03), diabetes mellitus (HR, 1.37; P=0.03), low serum albumin (HR, 0.76 per 1-g/dL decrease; P=0.02), and use of an erythropoietin-stimulating agent (HR, 1.62; P=0.02) were risk factors for VA problems. The post-PTA patency rate was associated with aging (HR, 1.02; P<0.001), diabetes mellitus (HR, 1.49; P=0.02), polycystic kidney disease (HR, 2.14; P=0.01), temporary catheter use for initiation of HD (HR, 1.60; P=0.02), and period from VA construction to use (HR, 0.99; P=0.04).

Conclusion: Although a poor patency rate is commonly associated with advanced age and diabetes, different risk factors affect patency between VA construction and the first PTA.

論文の公開元へ

この論文で使われている画像

関連論文

関連論文をもっと見る

参考文献

1. Thomas B, Wulf S, Bikbov B, et al. Maintenance Dialysis Throughout the World in Years 1990 and 2010. J Am Soc Nephrol 2015; 26: 2621-2633.

2. Nitta K, Masakane S, Hanafusa N, et al. 2018 Annual Dialysis Data Report, JSDT Renal Data Registry. J Jpn Soc Dial Ther 2019; 52: 679- 754.

3. House AA, Wanner C, Sarnak MJ, et al. Heart Failure in Chronic Kidney Disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2019; 95: 1304-1317.

4. Dalrymple LS, Johansen KL, Chertow GM, et al. Infection-Related Hospitalizations in Older Patients with ESRD. Am J Kidney Dis 2010; 56: 522-530.

5. Salahi H, Fazelzadeh A, Mehdizadeh A, et al. Complications of Arteriovenous Fistula in Dialysis Patients. Transplant Proc 2006; 38: 1261-1264.

6. Al-Jaishi AA, Liu AR, Lok CE, et al. Complications of the Arteriovenous Fistula: A Systematic Review. J Am Soc Nephrol 2017; 28: 1839-1850.

7. Takemoto Y, Naganuma, T. The Economic Issue of Vascular Access within the Japanese Medical Reimbursement System. J Vasc Access 2015; 16 Suppl 10: S9-12.

8. Ravani P, Gillespie BW, Quinn RR, et al. Temporal Risk Profile for Infectious and Noninfectious Complications of Hemodialysis Access. J Am Soc Nephrol 2013; 24: 1668- 1677.

9. Ravani P, Quinn R, Oliver M, et al. Examining the Association between Hemodialysis Access Type and Mortality: The Role of Access Complications. Clin J Am Soc Nephrol 2017; 12: 955-964.

10. Ravani P, Palmer SC, Oliver MJ, et al. Associations between Hemodialysis Access Type and Clinical Outcomes: A Systematic Review. J Am Soc Nephrol 2013; 24: 465-473.

11. National Kidney Foundation. III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: Update 2000. Am J Kidney Dis 2001; 37: S137-181.

12. Lok CE. Fistula First Initiative: Advantages and Pitfalls. Clin J Am Soc Nephrol 2007; 2: 1043- 1053.

13. Hod T, Desilva RN, Patibandla BK, et al. Factors Predicting Failure of AV "fistula first" Policy in the Elderly. Hemodial Int 2014; 18: 507-515.

14. Baktiroglu S, Yanar F, Ozturk A. Brachiocephalic and Basilic Fistula. J Vasc Access 2015; 16 Suppl 9: S29-33.

15. Lee T, Thamer M, Zhang Q, et al. Vascular Access Type and Clinical Outcomes among Elderly Patients on Hemodialysis. Clin J Am Soc Nephrol 2017; 12: 1823-1830.

16. Mickley V. Stenosis and Thrombosis in Haemodialysis Fistulae and Grafts: The Surgeon's Point of View. Nephrol Dial Transplant 2004; 19: 309-311.

17. Rocco MV, Bleyer AJ, Burkart JM. Utilization of Inpatient and Outpatient Resources for the Management of Hemodialysis Access Complications. Am J Kidney Dis 1996; 28: 250- 256.

18. Kukita K, Ohira S, Amano I, et al. 2011 Update Japanese Society for Dialysis Therapy Guidelines of Vascular Access Construction and Repair for Chronic Hemodialysis. Ther Apher Dial 2015; 19 Suppl 1: 1-39.

19. Turmel-Rodrigues L, Pengloan J, Baudin S, et al. Treatment of Stenosis and Thrombosis in Haemodialysis Fistulas and Grafts by Interventional Radiology. Nephrol Dial Transplant 2000; 15: 2029-2036.

20. Miquelin DG, Reis LF, da Silva AA, et al. Percutaneous Transluminal Angioplasty in the Treatment of Stenosis of Arteriovenous Fistulae for Hemodialysis. Int Arch Med 2008; 1: 16.

21. Abreo K, Amin BM, Abreo AP. Physical Examination of the Hemodialysis Arteriovenous Fistula to Detect Early Dysfunction. J Vasc Access 2019; 20: 7-11.

22. Arhuidese IJ, Orandi BJ, Nejim B, et al. Utilization, Patency, and Complications Associated with Vascular Access for Hemodialysis in the United States. J Vasc Surg 2018; 68: 1166-1174.

23. Lok CE, Sontrop JM, Tomlinson G, et al. Cumulative Patency of Contemporary Fistulas Versus Grafts (2000–2010). Clin J Am Soc Nephrol 2013; 8: 810-818.

24. Al-Jaishi AA, Oliver MJ, Thomas SM, et al. Patency Rates of the Arteriovenous Fistula for Hemodialysis: A Systematic Review and Meta- Analysis. Am J Kidney Dis 2014; 63: 464-478.

25. Milburn JA, Lo ST, Szucs ZJ, et al. Transposed Brachiobasilic Fistula or PTFE Arm Graft - Alternative or Complementary? J Vasc Access 2008; 9: 117-121.

26. Windus DW. Permanent Vascular Access: A Nephrologist's View. Am J Kidney Dis 1993; 21: 457-471.

27. Pisoni RL, Zepel L, Fluck R, et al. International Differences in the Location and Use of Arteriovenous Accesses Created for Hemodialysis: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2018; 71: 469-478.

28. Ito Y, Sato T, Okada R, et al. Comparison of Clinical Effectiveness between Surgical and Endovascular Treatment for Thrombotic Obstruction in Hemodialysis Access. J Vasc Access 2011; 12: 63-66.

29. Chan MR, Sanchez RJ, Young HN, et al. Vascular Access Outcomes in the Elderly Hemodialysis Population: A USRDS Study. Semin Dial 2007; 20: 606-610.

30. Miller CD, Robbin ML, Allon M. Gender Differences in Outcomes of Arteriovenous Fistulas in Hemodialysis Patients. Kidney Int 2003; 63: 346-352.

31. Besarab A, Bolton WK, Browne JK, et al. The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and Epoetin. N Engl J Med 1998; 339: 584-590.

32. Wong V, Ward R, Taylor J, et al. Factors Associated with Early Failure of Arteriovenous Fistulae for Haemodialysis Access. Eur J Vasc Endovasc Surg 1996; 12: 207-213.

33. Smith GE, Gohil R, Chetter IC. Factors Affecting the Patency of Arteriovenous Fistulas for Dialysis Access. J Vasc Surg 2012; 55: 849- 855.

34. Stolic RV, Trajkovic GZ, Kostic MM, et al. Factors Affecting the Patency of Arteriovenous Fistulas for Hemodialysis: Single Center Experience. Hemodial Int 2018; 22: 328-334.

35. Almasri J, Alsawas M, Mainou M, et al. Outcomes of Vascular Access for Hemodialysis: A Systematic Review and Meta- Analysis. J Vasc Surg 2016; 64: 236-243.

36. Kim YO, Song HC, Yoon SA, et al. Preexisting Intimal Hyperplasia of Radial Artery Is Associated with Early Failure of Radiocephalic Arteriovenous Fistula in Hemodialysis Patients. Am J Kidney Dis 2003; 41: 422-428.

37. KDIGO. Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2012; 2: 1-138.

38. Lee TL, Chen CF, Tan AC, et al. Prognosis of Vascular Access in Haemodialysis Patients with Autosomal Dominant Polycystic Kidney Disease. Sci Rep 2020; 10: 1985.

39. Chandra M, Miller ME, Garcia JF, et al. Serum Immunoreactive Erythropoietin Levels in Patients with Polycystic Kidney Disease as Compared with Other Hemodialysis Patients. Nephron 1985; 39: 26-29.

40. Ushio Y, Kataoka H, Sato M, et al. Association between Anemia and Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study. Clin Exp Nephrol 2020; 24: 500-508.

41. Weyde W, Krajewska M, Penar J, et al. Vascular Abnormalities in Patients with Autosomal Dominant Polycystic Kidney Disease--the Influence on Arteriovenous Fistula Creation. Clin Nephrol 2004; 61: 344- 346.

42. Xing X, Lu J, Wang Z. Associated Risk Factors for Chronic Kidney Disease of Unknown Etiologies in 241 Patients. Int J Artif Organs 2015; 38: 184-191.

43. Chawla LS, Kimmel PL. Acute Kidney Injury and Chronic Kidney Disease: An Integrated Clinical Syndrome. Kidney Int 2012; 82: 516- 524.

44. Wakamoto K, Doi S, Nakashima A, et al. Comparing the 12-Month Patency of Low- Versus High-Pressure Dilation in Failing Arteriovenous Fistulae: A Prospective Multicenter Trial (YOROI Study). J Vasc Access 2018; 19: 477-483.

45. Doi S, Masaki T, Shigemoto K, et al. Calcium Channel Antagonists Reduce Restenosis after Percutaneous Transluminal Angioplasty of an Arteriovenous Fistula in Hemodialysis Patients. Ther Apher Dial 2008; 12: 232-236.

46. Brahmbhatt A, Remuzzi A, Franzoni M, et al. The Molecular Mechanisms of Hemodialysis Vascular Access Failure. Kidney Int 2016; 89: 303-316.

47. Vazquez-Padron RI, Allon M. New Insights into Dialysis Vascular Access: Impact of Preexisting Arterial and Venous Pathology on AVF and AVG Outcomes. Clin J Am Soc Nephrol 2016; 11: 1495-1503.

48. Chang CJ, Ko PJ, Hsu LA, et al. Highly Increased Cell Proliferation Activity in the Restenotic Hemodialysis Vascular Access after Percutaneous Transluminal Angioplasty: Implication in Prevention of Restenosis. Am J Kidney Dis 2004; 43: 74-84.

49. Lee T, Misra S. New Insights into Dialysis Vascular Access: Molecular Targets in Arteriovenous Fistula and Arteriovenous Graft Failure and Their Potential to Improve Vascular Access Outcomes. Clin J Am Soc Nephrol 2016; 11: 1504-1512.

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文
を
一発検索！

この論文の関連論文を見る